Avanos Medical (AVNS) Share-based Compensation (2013 - 2026)

Avanos Medical has disclosed Share-based Compensation across 14 years of filings, most recently posting $3.7 million for Q1 2026.

• In Q1 2026, Share-based Compensation fell 2.63% year-over-year to $3.7 million; the TTM figure through Mar 2026 stood at $12.5 million (down 10.71% YoY), while the FY2025 annual figure was $12.6 million, down 8.7% from the prior year.
• Share-based Compensation came in at $3.7 million for Q1 2026 at Avanos Medical, up from $1.2 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $4.1 million in Q3 2022 to a low of $1.2 million in Q4 2025.
• Average Share-based Compensation over 5 years is $3.6 million, with a median of $3.8 million recorded in 2022.
• The largest YoY upside for Share-based Compensation was 34.62% in 2025 against a maximum downside of 68.42% in 2025.
• Over 5 years, Share-based Compensation stood at $4.0 million in 2022, then changed by 0.0% to $4.0 million in 2023, then dropped by 5.0% to $3.8 million in 2024, then sank by 68.42% to $1.2 million in 2025, then soared by 208.33% to $3.7 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $3.7 million in Q1 2026, $1.2 million in Q4 2025, and $3.5 million in Q3 2025.